Business
GoodRx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings Inc., a leading consumer-focused digital healthcare platform in the United States, today announced
About this update from Goodrx Holdings, Inc.
[{"type":"text","content":" SANTA MONICA, Calif.--(BUSINESS WIRE)--\nGoodRx Holdings Inc., a leading consumer-focused digital healthcare platform in the United States, today announced the closing of its initial public offering of 39,807,691 shares of its Class A common stock at a price to the public of $33.00 per share. Of the offered shares, 28,615,034 shares were offered by GoodRx and 11,192,657 shares were offered by certain selling shareholders. The number of shares offered and sold by GoodRx included the exercise in full of the underwriters’ option to purchase up to an additional 5,192,307 shares of Class A common stock from GoodRx. GoodRx will not receive any proceeds from any sale of shares by the selling shareholders.\n\nGoodRx’s common stock began trading on the NASDAQ Global Select Market on September 23, 2020, under the ticker symbol “GDRX”.\n\nMorgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan and Barclays acted as lead bookrunners for the offering. BofA Securities, Citigroup, Credit Suisse Securities (USA) LLC, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, and Evercore ISI acted as additional bookrunners, and Citizens Capital Markets, KKR Capital Markets, LionTree Advisors, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus & Co., LLC and Ramirez & Co., Inc. acted as co-managers for the offering.\n\nCopies of the final prospectus relating to this offering may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected]; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, collect telephone: 1-212-834-4533, or by emailing at [email protected]; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] or telephone at 1-888-603-5847.\n\nIn addition to the shares of Class A common stock sold in the public offering, GoodRx announced that entities affiliated with Silver Lake, an existing stockholder, purchased 3,030,303 shares of Class A common stock in a priva...